Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling

Bibliographic Data

ID14729632
AuthorsNannan Shen (Harbin Medical University), Xiaoguang Li (0000-0002-2362-9130, Harbin Medical University), Tong Zhou (0000-0003-3901-3477, Harbin Medical University), Muhammad Bilal (0000-0001-5388-3183, Harbin Medical University), Muhammad U Bilal, Ning Du (0000-0003-3025-4629, Harbin Medical University), Yingying Hu (0000-0001-7791-6058, Harbin Medical University), Wei Qin (0000-0002-9199-966X, Harbin Medical University), Yingming Xie (0000-0001-7939-6762, Harbin Medical University), Hongtao Wang (0000-0002-1013-5713, Shijiazhuang Yiling Pharmaceutical (China)), Jiayue Wu (0000-0002-3394-1507, Harbin Medical University), Jianwei Wu (0000-0003-3881-0925), Jiaming Ju (0009-0009-1883-9000, Harbin Medical University), Zhiwei Fang (0000-0001-8826-8834, Harbin Medical University), Lihong Wang (0009-0002-7085-301X, Harbin Medical University, corresponding author), Yong Zhang (0000-0001-6711-5791, Harbin Medical University, corresponding author)
Year2014
Volume157
Pages161-170
Publication date2014-11-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueJournal of Ethnopharmacology (JOURNAL)
Journal identifiersISSN: 0378-8741 • E-ISSN: 1872-7573
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.jep.2014.09.035
PMID25267579
OpenAlexW2083739982
LanguageEN
Citations received3
References cited33